Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2012 - Documents - Presentations -
DatumBeschreibungGrößeAutor Dokument 
11.04.13Plenary Session I: ‘A look ahead’33blankintext/x-cms-note
11.04.13Frequency of Huntington Disease - Greater than you think9 kBblankinapplication/pdf
11.04.13What are we really looking for in an HD drug?9 kBblankinapplication/pdf
11.04.13Care, coping and research in HD – the earlier the better!9 kBblankinapplication/pdf
11.04.13Plenary Session II: ‘Frontiers in biology and their relevance to Huntington’s disease’ 33blankintext/x-cms-note
11.04.13Longevity pathways and their relevance to human disease9 kBblankinapplication/pdf
11.04.13RNA toxicity in poly-Q disorders3.3 MBblankinapplication/pdf
11.04.13Post-translational modifications and proteolysis of huntingtin9 kBblankinapplication/pdf
11.04.13Plenary Session III: ‘Science practice at EHDN’ 33blankintext/x-cms-note
11.04.13Scientific strategy of EHDN: implementation126 kBblankinapplication/pdf
11.04.13Juvenile HD Working Group441 kBblankinapplication/pdf
11.04.13Advanced HD Working Group9 kBblankinapplication/pdf
11.04.13Animal studies on the effects of physiotherapy9 kBblankinapplication/pdf
11.04.13Human physiotherapy studies9 kBblankinapplication/pdf
11.04.13Short Communications I: 'Scientific Presentations: 10’ and 5’ questions – selected from submissions' 33blankintext/x-cms-note
11.04.13Default-mode network changes in preclinical Huntington´s disease9 kBblankinapplication/pdf
11.04.13Longitudinal functional and connectivity changes during working memory performance in HD9 kBblankinapplication/pdf
11.04.13Better global and cognitive functioning for choreatic compared to hypokinetic- rigid HD9 kBblankinapplication/pdf
11.04.13Critical consideration of the criteria for the motor diagnosis of HD9 kBblankinapplication/pdf
11.04.13Plenary Session IV: Keynote presentations33blankintext/x-cms-note
11.04.13Update on stem cell research: clinical potentials9 kBblankinapplication/pdf
11.04.13Cognitive alterations in HD9 kBblankinapplication/pdf
11.04.13Roundup I33blankintext/x-cms-note
11.04.13Lessons of the day9 kBblankinapplication/pdf
11.04.13Breakfast teaching courses Sat33blankintext/x-cms-note
11.04.13Clinical management of Huntington’s disease9 kBblankinapplication/pdf
11.04.13Differential diagnosis of chorea9 kBblankinapplication/pdf
11.04.13Behavioral assessment and management of behavioral issues9 kBblankinapplication/pdf
11.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
11.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
11.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
11.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
11.04.13Plenary Session V: ‘Understanding and manipulating the pathogenic process in Huntington’s disease’ 33blankintext/x-cms-note
11.04.13Huntingtin7.9 MBblankinapplication/pdf
11.04.13Post-translational modifications of huntingtin9 kBblankinapplication/pdf
11.04.13Stem cells for basic research on HD1.8 MBblankinapplication/pdf
11.04.13Stem cells for basic research on HD9 kBblankinapplication/pdf
11.04.13Plenary Session VI: Keynote presentations33blankintext/x-cms-note
11.04.13Keynote presentations9 kBblankinapplication/pdf
11.04.13Updates on lowering huntingtin (htt) levels9 kBblankinapplication/pdf
11.04.13Short communications II: Scientific presentations33blankintext/x-cms-note
11.04.13HDAC4 interacts with huntingtin and HDAC4 reduction decreases cytoplasmic aggregation and rescues synaptic dysfunction in HD mouse models9 kBblankinapplication/pdf
11.04.13Aging pathway and poly-Q neurotoxicity656 kBblankinapplication/pdf
11.04.13NeuroNet and its potential for the study of neurodegeneration9 kBblankinapplication/pdf
11.04.13Phenotyping neural networks in an ovine model of HD9 kBblankinapplication/pdf
11.04.13Plenary Session VII: ‘Therapeutic development programs in Huntington’s Disease’33blankintext/x-cms-note
11.04.13Overview of CHDI drug development programs3.5 MBblankinapplication/pdf
11.04.13Htt lowering: Medtronic-Alnylam/Isis/CHDI9 kBblankinapplication/pdf
11.04.13Sirt1-inhibition: SienaBiotech9 kBblankinapplication/pdf
11.04.13PDE-10-inhibition: Pfizer9 kBblankinapplication/pdf
11.04.13PDE-4-inhibition: GSK9 kBblankinapplication/pdf
11.04.13Bupropion: ACTION-HD9 kBblankinapplication/pdf
11.04.13PREQUEL EHDN9 kBblankinapplication/pdf
11.04.13Reach2HD PBT29 kBblankinapplication/pdf
11.04.13Dopaminergic stabilization in HD: pridopidine9 kBblankinapplication/pdf
08.04.13Plenary Session VIII: EHDN Business Meeting33blankintext/x-cms-note
08.04.13EHDN Update - EC elections, SBAC elections, Structure of EHDN9 kBblankinapplication/pdf
08.04.13Presentation of the HDYO website2.5 MBblankinapplication/pdf
08.04.13Standards of Care9 kBblankinapplication/pdf
08.04.13Roundup II33blankintext/x-cms-note
08.04.13Lessons of the day9 kBblankinapplication/pdf
08.04.13Breakfast teaching courses Sun33blankintext/x-cms-note
08.04.13Drug discovery and development process9 kBblankinapplication/pdf
08.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
08.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
08.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
08.04.13Training on HD assessments including HD-CC9 kBblankinapplication/pdf
08.04.13HD for Basic Scientists9 kBblankinapplication/pdf
08.04.13Common issues/problems/inconsistencies in HD assessments9 kBblankinapplication/pdf
08.04.13Plenary Session IX: ‘Tools and outcome to monitor disease progression and response to therapy’33blankintext/x-cms-note
08.04.13Brain imaging as a potential marker for HD (PET)9 kBblankinapplication/pdf
08.04.13MRI as a potential marker for HD971 kBblankinapplication/pdf
08.04.13Defining predictors of disease1.9 MBblankinapplication/pdf
08.04.13New assessment tools (cognitive batteries)9 kBblankinapplication/pdf
08.04.13New assessment tools (cognitive batteries)9 kBblankinapplication/pdf
08.04.13REGISTRY and Enroll-HD9 kBblankinapplication/pdf
08.04.13Poster Awards9 kBblankinapplication/pdf
08.04.13Roundup III33blankintext/x-cms-note
08.04.13Progress in HD research and HD advocacy: a personal view9 kBblankinapplication/pdf
08.04.13EHA meeting33blankintext/x-cms-note
08.04.13Falling in love, staying in love89 kBblankinapplication/pdf
08.04.13Oral Presentations33blankintext/x-cms-note
08.04.13Juvenile Huntington's disease662 kBblankinapplication/pdf
08.04.13Default-mode network changes in preclinical Huntington’s disease1.5 MBblankinapplication/pdf
08.04.13Better global and cognitive functioning for choreatic compared to hypokinetic-rigid Huntington’s disease380 kBblankinapplication/pdf
08.04.13Critical consideration of the criteria for the motor diagnosis of HD387 kBblankinapplication/pdf
08.04.13Induced Pluripotent Stem cells for basic and translational research on HD2.0 MBblankinapplication/pdf

Verzeichnis enthält 87 Dokumente.